Skip to Main Content

Paper Details

Proxalutamide reduces SARS-CoV-2 infection and associated inflammatory response.
Proc Natl Acad Sci U S A
2
2023
AR, AR protein, COVID-19, NRF2, Proxalutamide, SARS, SARS-, SARS-CoV, SARS-CoV-2, SARS-CoV-2 virus, advanced prostate cancer, androgen, androgen receptor, androgen-regulated gene, enzalutamide, interferon gamma, lung inflammation, mice, patients, proxalutamide, remdesivir, tumor necrosis factor alpha
Author NameAffiliation
Xuhong CaoMichigan Center for Translational Pathology, University of Michigan ann arbor
Jun QinBeijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics
Arul M ChinnaiyanMichigan Center for Translational Pathology, University of Michigan ann arbor
Arul M ChinnaiyanUniversity of Michigan ann arbor
Arul M ChinnaiyanRogel Cancer Center, University of Michigan ann arbor
Arul M ChinnaiyanUniversity of Michigan ann arbor
Arul M ChinnaiyanUniversity of Michigan ann arbor
Arul M ChinnaiyanMichigan Center for Translational Pathology, University of Michigan ann arbor
Arul M ChinnaiyanUniversity of Michigan ann arbor
Arul M ChinnaiyanRogel Cancer Center, University of Michigan ann arbor
Arul M ChinnaiyanUniversity of Michigan ann arbor
Arul M ChinnaiyanUniversity of Michigan ann arbor
  • 1 - 12

Datasets

Release 1.2